| Year |
Citation |
Score |
| 2023 |
Dimond MG, Ibrahim NE, Fiuzat M, McMurray JJV, Lindenfeld J, Ahmad T, Bozkurt B, Bristow MR, Butler J, Carson PE, Felker GM, Jessup M, Murillo J, Kondo T, Solomon SD, et al. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping. Jacc. Heart Failure. PMID 38099892 DOI: 10.1016/j.jchf.2023.11.005 |
0.35 |
|
| 2023 |
Tatman PD, Kao DP, Chatfield KC, Carroll IA, Wagner JA, Jonas ER, Sucharov CC, Port JD, Lowes BD, Minobe WA, Huebler SP, Karimpour-Fard A, Rodriguez EM, Liggett SB, Bristow MR. An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies. Jci Insight. 8. PMID 37606047 DOI: 10.1172/jci.insight.169720 |
0.536 |
|
| 2022 |
Zhao Y, Riching AS, Knight WE, Chi C, Broadwell LJ, Du Y, Abdel-Hafiz M, Ambardekar AV, Irwin DC, Proenza C, Xu H, Leinwand LA, Walker LA, Woulfe KC, Bristow MR, et al. Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart. Circulation. 101161CIRCULATIONAHA. PMID 35862102 DOI: 10.1161/CIRCULATIONAHA.121.058017 |
0.377 |
|
| 2022 |
Cleland JGF, Bristow MR, Freemantle N, Olshansky B, Gras D, Saxon L, Tavazzi L, Boehmer J, Ghio S, Feldman AM, Daubert JC, deMets D. The Effect of Cardiac Resynchronization without a Defibrillator on Morbidity and Mortality: An Individual-Patient-Data Meta-Analysis of COMPANION and CARE-HF. European Journal of Heart Failure. PMID 35490339 DOI: 10.1002/ejhf.2524 |
0.318 |
|
| 2022 |
Bristow MR, Mann DL. Cardiac Adrenergic Activation in Heart Failure With Preserved Ejection Fraction: A Role for β-Blockade? Jacc. Basic to Translational Science. 7: 128-130. PMID 35257039 DOI: 10.1016/j.jacbts.2022.01.003 |
0.365 |
|
| 2022 |
Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, To S, Li G, Yeri A, Rodosthenous R, Silverman MG, Das S, Ambardekar AV, Bristow MR, Gonzalez-Rosa JM, et al. lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth. Circulation. PMID 35114812 DOI: 10.1161/CIRCULATIONAHA.121.056850 |
0.335 |
|
| 2021 |
Doran B, Mei C, Varosy PD, Kao DP, Saxon LA, Feldman AM, DeMets D, Bristow MR. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy. Jacc. Heart Failure. PMID 33992570 DOI: 10.1016/j.jchf.2021.02.013 |
0.328 |
|
| 2021 |
Purmah Y, Lei LY, Dykstra S, Mikami Y, Cornhill A, Satriano A, Flewitt J, Rivest S, Sandonato R, Seib M, Lydell CP, Howarth AG, Heydari B, Merchant N, Bristow M, et al. Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events: A Cardiac MRI Based Study of 7131 Patients With Known or Suspected Cardiovascular Disease. Circulation. Cardiovascular Imaging. CIRCIMAGING120011337. PMID 33722059 DOI: 10.1161/CIRCIMAGING.120.011337 |
0.303 |
|
| 2021 |
Beldhuis IE, Myhre PL, Bristow M, Claggett B, Damman K, Fang JC, Fleg JL, McKinlay S, Lewis EF, O'Meara E, Pitt B, Shah SJ, Vardeny O, Voors AA, Pfeffer MA, et al. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function. Journal of the American College of Cardiology. 77: 1211-1221. PMID 33663739 DOI: 10.1016/j.jacc.2020.12.057 |
0.319 |
|
| 2020 |
Bhatt AS, Abraham WT, Lindenfeld J, Bristow M, Carson PE, Felker GM, Fonarow GC, Greene SJ, Psotka MA, Solomon SD, Stockbridge N, Teerlink JR, Vaduganathan M, Wittes J, Fiuzat M, et al. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory. Jacc. Heart Failure. PMID 33309582 DOI: 10.1016/j.jchf.2020.10.014 |
0.334 |
|
| 2020 |
Bristow MR, Zisman LS, Altman NL, Gilbert EM, Lowes BD, Minobe WA, Slavov D, Schwisow JA, Rodriguez EM, Carroll IA, Keuer TA, Buttrick PM, Kao DP. Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium. Jacc. Basic to Translational Science. PMID 32838074 DOI: 10.1016/J.Jacbts.2020.06.007 |
0.602 |
|
| 2020 |
Haywood ME, Cocciolo A, Porter KF, Dobrinskikh E, Slavov D, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG. Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53. Journal of Molecular and Cellular Cardiology. PMID 31958463 DOI: 10.1016/J.Yjmcc.2019.12.010 |
0.439 |
|
| 2019 |
Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR. Correction: Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. Plos One. 14: e0224389. PMID 31639152 DOI: 10.1371/Journal.Pone.0224389 |
0.54 |
|
| 2019 |
Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR. Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. Plos One. 14: e0221519. PMID 31469842 DOI: 10.1371/Journal.Pone.0221519 |
0.582 |
|
| 2019 |
Piccini JP, Abraham WT, Dufton C, Carroll IA, Healey JS, van Veldhuisen DJ, Sauer WH, Anand IS, White M, Wilton SB, Aleong R, Rienstra M, Krueger SK, Ayala-Paredes F, Khaykin Y, ... ... Bristow MR, et al. GENETIC-AF: Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined Heart Failure Population. Jacc. Heart Failure. PMID 31042551 DOI: 10.1016/J.Jchf.2019.04.004 |
0.408 |
|
| 2019 |
Sucharov CC, Nakano SJ, Slavov D, Schwisow JA, Rodriguez E, Nunley K, Medway A, Stafford N, Nelson P, McKinsey TA, Movsesian M, Minobe W, Carroll IA, Taylor MRG, Bristow MR. A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium. Journal of the American College of Cardiology. 73: 1173-1184. PMID 30871701 DOI: 10.1016/J.Jacc.2018.12.053 |
0.413 |
|
| 2019 |
Shamoun F, De Marco T, DeMets D, Mei C, Lindenfeld J, Saxon LA, Boehmer JP, Leigh J, Yong P, Feldman AM, Bristow MR. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy. Jacc. Heart Failure. PMID 30738980 DOI: 10.1016/J.Jchf.2018.11.004 |
0.45 |
|
| 2019 |
Page S, Kwee L, Kraus W, White P, Devore A, Mentz R, Bristow M, Milano C, Bowles D, Ilkayeva O, Felker GM, Christopher B, Holley C, McGarrah R, Shah S. Abstract 933: Integrated Omics Analysis of Diabetic Heart Failure in Human Myocardium Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.933 |
0.389 |
|
| 2018 |
Sweet ME, Cocciolo A, Slavov D, Jones KL, Sweet JR, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. Bmc Genomics. 19: 812. PMID 30419824 DOI: 10.1186/S12864-018-5213-9 |
0.452 |
|
| 2018 |
Piccini JP, Connolly SJ, Abraham WT, Healey JS, Steinberg BA, Al-Khalidi HR, Dignacco P, van Veldhuisen DJ, Sauer WH, White M, Wilton SB, Anand IS, Dufton C, Marshall DA, Aleong RG, ... ... Bristow MR, et al. A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial. American Heart Journal. 199: 51-58. PMID 29754666 DOI: 10.1016/J.Ahj.2017.12.001 |
0.441 |
|
| 2018 |
O'Connor CM, Bristow MR. Changing the Research Culture in the United States. Jacc. Heart Failure. 6: 344-345. PMID 29598937 DOI: 10.1016/J.Jchf.2018.03.001 |
0.35 |
|
| 2018 |
O'Connor CM, Psotka MA, Fiuzat M, Lindenfeld J, Abraham WT, Bristow MR, Canos D, Harrington RA, Hillebrenner M, Jessup M, Malik FI, Solomon SD, Stockbridge N, Tcheng JE, Unger EF, et al. Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory. Journal of the American College of Cardiology. 71: 443-453. PMID 29389362 DOI: 10.1016/J.Jacc.2017.11.048 |
0.441 |
|
| 2018 |
Bristow MR. Contractile reserve and the response to cardiac resynchronization therapy. International Journal of Cardiology. 252: 234-235. PMID 29249434 DOI: 10.1016/J.Ijcard.2017.11.014 |
0.347 |
|
| 2017 |
Leary PJ, Kronmal RA, Bluemke DA, Buttrick PM, Jones KL, Kao DP, Kawut SM, Krieger EV, Lima JA, Minobe W, Ralph DD, Tedford RJ, Weiss NS, Bristow MR. Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial). The American Journal of Cardiology. PMID 29191567 DOI: 10.1016/J.Amjcard.2017.10.016 |
0.401 |
|
| 2017 |
Bristow MR, Kao DP, Breathett KK, Altman NL, Gorcsan J, Gill EA, Lowes BD, Gilbert EM, Quaife RA, Mann DL. Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete? Jacc. Heart Failure. 5: 772-781. PMID 29096787 DOI: 10.1016/J.Jchf.2017.09.009 |
0.669 |
|
| 2017 |
Bristow MR, Altman NL. Heart Rate in Preserved Ejection Fraction Heart Failure. Jacc. Heart Failure. PMID 29032133 DOI: 10.1016/J.Jchf.2017.09.004 |
0.456 |
|
| 2017 |
Shah P, Bristow MR, Port JD. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Current Heart Failure Reports. PMID 28940102 DOI: 10.1007/S11897-017-0362-8 |
0.482 |
|
| 2017 |
Kalscheur MM, Saxon LA, Lee BK, Steinberg JS, Mei C, Buhr KA, DeMets DL, Bristow MR, Singh SN. Outcomes of Cardiac Resynchronization Therapy in Patients with Intermittent Atrial Fibrillation or Atrial Flutter in the COMPANION Trial. Heart Rhythm. PMID 28323173 DOI: 10.1016/J.Hrthm.2017.03.024 |
0.43 |
|
| 2017 |
Bristow MR. Genetic variation expressed in the brain may impact heart failure. European Journal of Heart Failure. 19: 324-325. PMID 28251773 DOI: 10.1002/Ejhf.745 |
0.386 |
|
| 2017 |
Sucharov CC, Kao DP, Port JD, Karimpour-Fard A, Quaife RA, Minobe W, Nunley K, Lowes BD, Gilbert EM, Bristow MR. Myocardial microRNAs associated with reverse remodeling in human heart failure. Jci Insight. 2: e89169. PMID 28138556 DOI: 10.1172/Jci.Insight.89169 |
0.587 |
|
| 2016 |
Port JD, Bristow MR. Fine Tuning Adenylyl Cyclase as a (Gene) Therapy for Heart Failure. Jacc. Basic to Translational Science. 1: 630-632. PMID 30167546 DOI: 10.1016/J.Jacbts.2016.10.005 |
0.452 |
|
| 2016 |
Leary PJ, Bristow MR. Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure? Journal of the American College of Cardiology. 68: 2029-2030. PMID 27788859 DOI: 10.1016/J.Jacc.2016.07.774 |
0.335 |
|
| 2016 |
Bristow MR, Enciso JS, Gersh BJ, Grady C, Rice MM, Singh S, Sopko G, Boineau R, Rosenberg Y, Greenberg BH. Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations. Jacc. Basic to Translational Science. 1: 180-189. PMID 27747305 DOI: 10.1016/J.Jacbts.2016.03.001 |
0.385 |
|
| 2016 |
Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction. Circulation. Heart Failure. 9. PMID 27656000 DOI: 10.1161/Circheartfailure.115.002962 |
0.406 |
|
| 2016 |
Bristow MR, Saxon LA, Feldman AM, Mei C, Anderson SA, DeMets DL. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial. Jacc. Heart Failure. PMID 27289408 DOI: 10.1016/J.Jchf.2016.02.019 |
0.449 |
|
| 2016 |
Leary PJ, Tedford RJ, Bluemke DA, Bristow MR, Heckbert SR, Kawut SM, Krieger EV, Lima JA, Masri CS, Ralph DD, Shea S, Weiss NS, Kronmal RA. Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study. Journal of the American College of Cardiology. 67: 1544-52. PMID 27150686 DOI: 10.1016/J.Jacc.2016.01.045 |
0.44 |
|
| 2015 |
Bristow MR, Quaife RA. The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series). Pulmonary Circulation. 5: 415-23. PMID 26401244 DOI: 10.1086/682223 |
0.449 |
|
| 2015 |
Kao DP, Lowes BD, Gilbert EM, Minobe W, Epperson LE, Meyer LK, Ferguson DA, Volkman AK, Zolty R, Borg CD, Quaife RA, Bristow MR. Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy. Circulation. Cardiovascular Genetics. 8: 270-83. PMID 25637602 DOI: 10.1161/Circgenetics.114.000767 |
0.676 |
|
| 2015 |
Feldman AM, She L, McNamara DM, Mann DL, Bristow MR, Maisel AS, Wagner DR, Andersson B, Chiariello L, Hayward CS, Hendry P, Parker JD, Racine N, Selzman CH, Senni M, et al. Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials. Cardiology. 130: 69-81. PMID 25592552 DOI: 10.1159/000368221 |
0.387 |
|
| 2015 |
Aleong R, Ambardekar A, Davis G, Bristow MR. Bucindolol Prevents Atrial Flutter via the Beta-1 389 Arg/Gly Adrenergic Receptor Polymorphism Journal of Cardiac Failure. 21: S49. DOI: 10.1016/J.Cardfail.2015.06.167 |
0.416 |
|
| 2014 |
Taylor MR, Sun AY, Davis G, Fiuzat M, Liggett SB, Bristow MR. Race, common genetic variation, and therapeutic response disparities in heart failure. Jacc. Heart Failure. 2: 561-72. PMID 25443111 DOI: 10.1016/J.Jchf.2014.06.010 |
0.369 |
|
| 2014 |
Leary PJ, Barr RG, Bluemke DA, Bristow MR, Kronmal RA, Lima JA, Ralph DD, Ventetuolo CE, Kawut SM. H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study. Annals of the American Thoracic Society. 11: 1379-86. PMID 25295642 DOI: 10.1513/Annalsats.201407-344Oc |
0.323 |
|
| 2014 |
Aleong RG, Sauer WH, Davis G, Bristow MR. New-onset atrial fibrillation predicts heart failure progression. The American Journal of Medicine. 127: 963-71. PMID 24931393 DOI: 10.1016/J.Amjmed.2014.06.006 |
0.462 |
|
| 2014 |
Le CH, Mulligan CM, Routh MA, Bouma GJ, Frye MA, Jeckel KM, Sparagna GC, Lynch JM, Moore RL, McCune SA, Bristow M, Zarini S, Murphy RC, Chicco AJ. Delta-6-desaturase links polyunsaturated fatty acid metabolism with phospholipid remodeling and disease progression in heart failure. Circulation. Heart Failure. 7: 172-83. PMID 24284026 DOI: 10.1161/Circheartfailure.113.000744 |
0.398 |
|
| 2014 |
Kao DP, Minobe W, Jones KL, Zolty R, Gilbert EM, Lowes BD, Bristow MR. RNA Sequencing, Microarray Hybridization, and Quantitative PCR Produce Complementary, Concordant Results in Longitudinal Analysis of Myocardial Gene Expression in Dilated Cardiomyopathy Patients Journal of Cardiac Failure. 20: S82. DOI: 10.1016/J.Cardfail.2014.06.233 |
0.666 |
|
| 2013 |
Bristow MR, Aleong RG. Treatment of the heart failure patient with atrial fibrillation: a major unmet need. Jacc. Heart Failure. 1: 29-30. PMID 24621796 DOI: 10.1016/J.Jchf.2012.10.001 |
0.481 |
|
| 2013 |
Aleong RG, Sauer WH, Sauer WH, Murphy GA, Port JD, Anand IS, Fiuzat M, O'Connor CM, Abraham WT, Liggett SB, Bristow MR. Prevention of atrial fibrillation by bucindolol is dependent on the betaâ‚389 Arg/Gly adrenergic receptor polymorphism. Jacc. Heart Failure. 1: 338-44. PMID 24159564 DOI: 10.1016/J.Jchf.2013.04.002 |
0.45 |
|
| 2013 |
Fiuzat M, O'Connor CM, Gueyffier F, Mascette AM, Geller NL, Mebazaa A, Voors AA, Adams KF, Piña IL, Neyses L, Muntendam P, Felker GM, Pitt B, Zannad F, Bristow MR. Biomarker-guided therapies in heart failure: a forum for unified strategies. Journal of Cardiac Failure. 19: 592-9. PMID 23910590 DOI: 10.1016/J.Cardfail.2013.05.012 |
0.442 |
|
| 2013 |
Feldman AM, Mann DL, She L, Bristow MR, Maisel AS, McNamara DM, Walsh R, Lee DL, Wos S, Lang I, Wells G, Drazner MH, Schmedtje JF, Pauly DF, Sueta CA, et al. Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circulation. Heart Failure. 6: 461-72. PMID 23584092 DOI: 10.1161/Circheartfailure.112.000185 |
0.331 |
|
| 2013 |
Aleong RG, Sauer WH, Robertson AD, Liggett SB, Bristow MR. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure Circulation: Arrhythmia and Electrophysiology. 6: 137-143. PMID 23275278 DOI: 10.1161/Circep.111.969618 |
0.424 |
|
| 2013 |
Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, ... Bristow MR, et al. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. European Journal of Heart Failure. 15: 324-33. PMID 23223178 DOI: 10.1093/Eurjhf/Hfs181 |
0.499 |
|
| 2013 |
Hinterberg MA, Kao D, Karimpour-Fard A, Sucharov K, Hunter LE, Port D, Bristow M. MYOCARDIAL EXPRESSION OF THE MICRORNA DRE-MIR-133A-5P IS ASSOCIATED WITH IMPROVEMENT IN LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY TREATED WITH BETA-BLOCKERS Journal of the American College of Cardiology. 61: E714. DOI: 10.1016/S0735-1097(13)60714-7 |
0.452 |
|
| 2013 |
Aleong R, Sauer WH, Davis G, Bristow MR. New Onset Atrial Fibrillation Is a Risk Factor for Ventricular Arrhythmias in Heart Failure Journal of Cardiac Failure. 19: S24. DOI: 10.1016/J.Cardfail.2013.06.082 |
0.424 |
|
| 2012 |
Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD. A Personalized BEST: Characterization of Latent Clinical Classes of Nonischemic Heart Failure That Predict Outcomes and Response to Bucindolol Plos One. 7. PMID 23144856 DOI: 10.1371/Journal.Pone.0048184 |
0.641 |
|
| 2012 |
Musunuru K, Roden DM, Boineau R, Bristow MR, McCaffrey TA, Newton-Cheh C, Paltoo DN, Rosenberg Y, Wohlgemuth JG, Zineh I, Hasan AA. Cardiovascular pharmacogenomics: current status and future directions-report of a national heart, lung, and blood institute working group. Journal of the American Heart Association. 1: e000554. PMID 23130127 DOI: 10.1161/Jaha.111.000554 |
0.31 |
|
| 2012 |
Ventetuolo CE, Lima JA, Barr RG, Bristow MR, Bagiella E, Chahal H, Kizer JR, Lederer DJ, Bluemke DA, Kawut SM. The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study. Pulmonary Circulation. 2: 379-86. PMID 23130107 DOI: 10.4103/2045-8932.101657 |
0.329 |
|
| 2012 |
O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Walsh R, Nelson P, Medway A, Davis G, Robertson AD, ... ... Bristow MR, et al. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. Plos One. 7: e44324. PMID 23071495 DOI: 10.1371/Journal.Pone.0044324 |
0.314 |
|
| 2012 |
Leary PJ, Barr RG, Bluemke DA, Bristow MR, Hough CL, Kronmal RA, Lima JA, McClelland RL, Tracy RP, Kawut SM. Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study). The American Journal of Cardiology. 110: 1846-51. PMID 22995970 DOI: 10.1016/J.Amjcard.2012.08.022 |
0.306 |
|
| 2012 |
Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)--right ventricle study. Circulation. 126: 1681-8. PMID 22932258 DOI: 10.1161/Circulationaha.112.095216 |
0.41 |
|
| 2012 |
Kao D, Davis G, Aleong R, Sauer W, Bristow MR. Effect of Bucindolol on Heart Failure Outcomes in HFREF Patients With Permanent Atrial Fibrillation Journal of Cardiac Failure. 18: S50-S51. DOI: 10.1016/J.Cardfail.2012.06.173 |
0.443 |
|
| 2012 |
Kao DP, Zolty R, Gilbert EM, Lowes BD, Bristow MR. Myocardial Gene Expression Associated With Right- and Left-Ventricular Remodeling With Beta-Blockade in Idiopathic Dilated Cardiomyopathy Journal of Cardiac Failure. 18: S33-S34. DOI: 10.1016/J.Cardfail.2012.06.116 |
0.71 |
|
| 2011 |
Bristow MR. Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology. Circulation Research. 109: 1176-94. PMID 22034480 DOI: 10.1161/Circresaha.111.245092 |
0.432 |
|
| 2011 |
Port JD, Bristow MR. Aptamer therapy for heart failure? Circulation Research. 109: 982-3. PMID 21998296 DOI: 10.1161/Circresaha.111.255661 |
0.421 |
|
| 2011 |
Fiuzat M, Bristow MR. Pharmacogenetics in heart failure trials. Heart Failure Clinics. 7: 553-9. PMID 21925439 DOI: 10.1016/J.Hfc.2011.06.010 |
0.419 |
|
| 2011 |
O'Connor CM, Fiuzat M, Swedberg K, Caron M, Koch B, Carson PE, Gattis-Stough W, Davis GW, Bristow MR. Influence of global region on outcomes in heart failure β-blocker trials. Journal of the American College of Cardiology. 58: 915-22. PMID 21851879 DOI: 10.1016/J.Jacc.2011.03.057 |
0.412 |
|
| 2011 |
Sucharov CC, Dockstader K, Nunley K, McKinsey TA, Bristow M. β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5. Journal of Cardiac Failure. 17: 592-600. PMID 21703532 DOI: 10.1016/J.Cardfail.2011.03.006 |
0.374 |
|
| 2011 |
Feiner EC, Chung P, Jasmin JF, Zhang J, Whitaker-Menezes D, Myers V, Song J, Feldman EW, Funakoshi H, Degeorge BR, Yelamarty RV, Koch WJ, Lisanti MP, McTiernan CF, Cheung JY, ... Bristow MR, et al. Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. Journal of Cardiac Failure. 17: 253-63. PMID 21362533 DOI: 10.1016/J.Cardfail.2010.10.008 |
0.429 |
|
| 2011 |
Dibble CT, Lima JA, Bluemke DA, Chirinos JA, Chahal H, Bristow MR, Kronmal RA, Barr RG, Ferrari VA, Propert KJ, Kawut SM. Regional left ventricular systolic function and the right ventricle: the multi-ethnic study of atherosclerosis right ventricle study. Chest. 140: 310-6. PMID 21330384 DOI: 10.1378/Chest.10-1750 |
0.391 |
|
| 2011 |
Kao DP, Wagner BD, Robertson AD, Kittelson JM, Bristow MR, Lowes BD. HIGH-DIMENSIONAL CLINICAL PHENOTYPE ANALYSIS PREDICTS MORTALITY AND RESPONSE TO BETA-BLOCKER THERAPY IN NONISCHEMIC HEART FAILURE Journal of the American College of Cardiology. 57: E1266. DOI: 10.1016/S0735-1097(11)61266-7 |
0.642 |
|
| 2011 |
Brieke A, Kao DP, Zolty R, Gilbert EM, Robertson AD, Bristow MR, Lowes BD. Transcriptional Profiles of Ventricular Ectopy on β-Blocker Therapy Journal of Cardiac Failure. 17: S35-S36. DOI: 10.1016/J.Cardfail.2011.06.120 |
0.673 |
|
| 2010 |
Bader FM, Gilbert EM, Mehta NA, Bristow MR. Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure. Congestive Heart Failure (Greenwich, Conn.). 16: 265-70. PMID 21091611 DOI: 10.1111/J.1751-7133.2010.00185.X |
0.437 |
|
| 2010 |
Carson P, Fiuzat M, O'Connor C, Anand I, Plehn J, Lindenfeld JA, Silver M, White M, Miller A, Davis G, Robertson AD, Bristow M, Gottlieb S. Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). American Heart Journal. 160: 649-54. PMID 20934558 DOI: 10.1016/J.Ahj.2010.07.004 |
0.327 |
|
| 2010 |
Kawut SM, Barr RG, Johnson WC, Chahal H, Tandri H, Jain A, Bristow MR, Kizer JR, Bagiella E, Lima JA, Bluemke DA. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 15: 731-8. PMID 20923324 DOI: 10.3109/1354750X.2010.516455 |
0.308 |
|
| 2010 |
Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. Journal of the American College of Cardiology. 56: 382-91. PMID 20650360 DOI: 10.1016/J.Jacc.2010.04.019 |
0.433 |
|
| 2010 |
Murphy GA, Fiuzat M, Bristow MR. Targeting heart failure therapeutics: a historical perspective. Heart Failure Clinics. 6: 11-23. PMID 19945056 DOI: 10.1016/J.Hfc.2009.08.008 |
0.381 |
|
| 2010 |
Bristow MR, Murphy GA, Krause-Steinrauf H, Anderson JL, Carlquist JF, Thaneemit-Chen S, Krishnan V, Abraham WT, Lowes BD, Port JD, Davis GW, Lazzeroni LC, Robertson AD, Lavori PW, Liggett SB. An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. Circulation. Heart Failure. 3: 21-8. PMID 19880803 DOI: 10.1161/Circheartfailure.109.885962 |
0.656 |
|
| 2010 |
Allen L, Fiuzat M, Davis G, Felker GM, Bristow M. Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST) Journal of Cardiac Failure. 16: S65. DOI: 10.1016/J.Cardfail.2010.06.224 |
0.445 |
|
| 2010 |
Lowes BD, Zolty R, Gilbert EM, Robertson AD, Bristow MR. Discovery and Validation of Novel Genes in Cardiac Remodeling Journal of Cardiac Failure. 16: S39. DOI: 10.1016/J.Cardfail.2010.06.135 |
0.692 |
|
| 2010 |
Lowes BD, Zolty R, Gilbert EM, Robertson AD, Bristow MR. Transcriptional Profiles of Reverse Remodeling Journal of Cardiac Failure. 16: S38-S39. DOI: 10.1016/J.Cardfail.2010.06.134 |
0.632 |
|
| 2009 |
Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, ... ... Bristow MR, et al. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. European Heart Journal. 30: 3015-26. PMID 19700774 DOI: 10.1093/Eurheartj/Ehp338 |
0.431 |
|
| 2009 |
Sumner AD, Boehmer JP, Saxon LA, Carson P, Feldman AM, Galle E, Bristow MR. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy. Congestive Heart Failure (Greenwich, Conn.). 15: 159-64. PMID 19627288 DOI: 10.1111/J.1751-7133.2009.00057.X |
0.411 |
|
| 2009 |
Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, Guarnieri T, Rao A, Yong P, Galle E, Leigh J, Ecklund F, Bristow MR. Influence of left ventricular lead location on outcomes in the COMPANION study. Journal of Cardiovascular Electrophysiology. 20: 764-8. PMID 19298563 DOI: 10.1111/J.1540-8167.2009.01444.X |
0.342 |
|
| 2009 |
Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O'Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, ... Bristow MR, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation. 119: 969-77. PMID 19204305 DOI: 10.1161/Circulationaha.108.793273 |
0.426 |
|
| 2009 |
MacGregor JF, Wachter SB, Munger M, Stoddard G, Bristow MR, Gilbert EM. Carvedilol produces sustained long-term benefits: follow-up at 12 years. Congestive Heart Failure (Greenwich, Conn.). 15: 5-8. PMID 19187400 DOI: 10.1111/J.1751-7133.2008.00038.X |
0.406 |
|
| 2009 |
Sharkey SW, Maron BJ, Nelson P, Parpart M, Maron MS, Bristow MR. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. Journal of Cardiology. 53: 53-7. PMID 19167638 DOI: 10.1016/J.Jjcc.2008.08.006 |
0.3 |
|
| 2009 |
Movsesian M, Stehlik J, Vandeput F, Bristow MR. Phosphodiesterase inhibition in heart failure. Heart Failure Reviews. 14: 255-63. PMID 19096931 DOI: 10.1007/S10741-008-9130-X |
0.4 |
|
| 2009 |
Taylor MR, Slavov D, Humphrey K, Zhao L, Cockroft J, Zhu X, Lavori P, Bristow MR, Mestroni L, Lazzeroni LC. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure. Pharmacogenetics and Genomics. 19: 35-43. PMID 18953265 DOI: 10.1097/Fpc.0B013E328317Cc57 |
0.473 |
|
| 2009 |
Brieke A, Shakar S, Zolty R, Minobe W, Bristow M, Lowes B. 332: Molecular Remodeling on Beta-Blocker Therapy in the Failing Human Heart The Journal of Heart and Lung Transplantation. 28: S181. DOI: 10.1016/J.Healun.2008.11.339 |
0.728 |
|
| 2009 |
O'Connor C, Fiuzat M, Caron M, Koch B, Davis G, Bristow M. Influence of Varying Geographic Populations on Outcomes in Large Beta-Blocker Trials in Heart Failure Journal of Cardiac Failure. 15: S75-S76. DOI: 10.1016/J.Cardfail.2009.06.174 |
0.422 |
|
| 2009 |
Kinugawa K, Jeong MY, Bristow MR, Long CS. Thyroid hormone receptor signaling in normal and failing heart Thyroid and Heart Failure: From Pathophysiology to Clinics. 79-88. DOI: 10.1007/978-88-470-1143-4_8 |
0.37 |
|
| 2008 |
Carnegie GK, Soughayer J, Smith FD, Pedroja BS, Zhang F, Diviani D, Bristow MR, Kunkel MT, Newton AC, Langeberg LK, Scott JD. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Molecular Cell. 32: 169-79. PMID 18951085 DOI: 10.1016/J.Molcel.2008.08.030 |
0.315 |
|
| 2008 |
Kline KG, Frewen B, Bristow MR, Maccoss MJ, Wu CC. High quality catalog of proteotypic peptides from human heart. Journal of Proteome Research. 7: 5055-61. PMID 18803417 DOI: 10.1021/Pr800239E |
0.345 |
|
| 2008 |
Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. Journal of Molecular and Cellular Cardiology. 45: 185-92. PMID 18582896 DOI: 10.1016/J.Yjmcc.2008.04.014 |
0.324 |
|
| 2008 |
Haddad GE, Saunders LJ, Crosby SD, Carles M, del Monte F, King K, Bristow MR, Spinale FG, Macgillivray TE, Semigran MJ, Dec GW, Williams SA, Hajjar RJ, Gwathmey JK. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiological Genomics. 33: 267-77. PMID 18303083 DOI: 10.1152/Physiolgenomics.00265.2007 |
0.402 |
|
| 2008 |
De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, ... ... Bristow MR, et al. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. Journal of Cardiac Failure. 14: 9-18. PMID 18226768 DOI: 10.1016/J.Cardfail.2007.08.003 |
0.621 |
|
| 2008 |
Metra M, Dei Cas L, Bristow MR. The pathophysiology of acute heart failure--it is a lot about fluid accumulation. American Heart Journal. 155: 1-5. PMID 18082481 DOI: 10.1016/j.ahj.2007.10.011 |
0.307 |
|
| 2008 |
Sauer WH, Bristow MR. The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. 21: 3-11. PMID 18044015 DOI: 10.1007/S10840-007-9170-5 |
0.355 |
|
| 2008 |
Young EA, Zolty R, Brieke A, Stees C, Ferguson D, Minobe W, Shakar S, Bristow MR, Lowes BD. Down-Regulation of Connexin43 in Heart Failure Is Reversed by Beta Blocker Therapy Journal of Cardiac Failure. 14: S76. DOI: 10.1016/J.Cardfail.2008.06.426 |
0.649 |
|
| 2008 |
Carson P, Gottleib S, Anand I, Plehn J, Silver M, Lindenfeld J, Chris O, Miller A, White M, Fiuzat M, Liggett SB, Davis G, Robertson AD, Bristow MR. Determination of Hospitalization Type by Investigator Case Report Form or Adjudication Committee in a Large Heart Failure Clinical Trial (BEST) Journal of Cardiac Failure. 14: S93. DOI: 10.1016/J.Cardfail.2008.06.258 |
0.373 |
|
| 2007 |
Lowes BD, Zolty R, Shakar SF, Brieke A, Gray N, Reed M, Calalb M, Minobe W, Lindenfeld J, Wolfel EE, Geraci M, Bristow MR, Cleveland J. Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 26: 1170-6. PMID 18022084 DOI: 10.1016/J.Healun.2007.08.003 |
0.691 |
|
| 2007 |
Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Journal of Cardiac Failure. 13: 769-73. PMID 17996827 DOI: 10.1016/J.Cardfail.2007.06.723 |
0.45 |
|
| 2007 |
Tate CW, Robertson AD, Zolty R, Shakar SF, Lindenfeld J, Wolfel EE, Bristow MR, Lowes BD. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). Journal of Cardiac Failure. 13: 732-7. PMID 17996821 DOI: 10.1016/J.Cardfail.2007.07.001 |
0.68 |
|
| 2007 |
Feldman AM, Oren RM, Abraham WT, Boehmer JP, Carson PE, Eichhorn E, Gilbert EM, Kao A, Leier CV, Lowes BD, Mathier MA, McGrew FA, Metra M, Zisman LS, Shakar SF, ... ... Bristow MR, et al. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. American Heart Journal. 154: 861-9. PMID 17967591 DOI: 10.1016/J.Ahj.2007.06.044 |
0.636 |
|
| 2007 |
Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, Maxey ML, McCune SA, Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. Journal of Lipid Research. 48: 1559-70. PMID 17426348 DOI: 10.1194/Jlr.M600551-Jlr200 |
0.43 |
|
| 2007 |
Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, ... Bristow M, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 115: 204-12. PMID 17190867 DOI: 10.1161/Circulationaha.106.629261 |
0.468 |
|
| 2007 |
Gray N, Lowes BD, Calalb M, Zolty R, Brieke A, Lindenfeld J, Shakar S, Wolfel E, Cleveland J, Bristow MR. Assist Devices Fail To Induce Reverse Fetal-Pattern Gene Expression Despite Administration of Beta Blockers Journal of Cardiac Failure. 13: S118. DOI: 10.1016/J.Cardfail.2007.06.460 |
0.569 |
|
| 2007 |
Sucharov CC, Dockstader K, Nelson P, Melhado K, Nunley K, Bristow MR. The β1Arg389 Polymorphism Increases Fetal Gene Program Expression in Human Non-Failing Male Subjects and in Neonate Rat Cardiac Myocytes Journal of Cardiac Failure. 13: S110. DOI: 10.1016/J.Cardfail.2007.06.433 |
0.313 |
|
| 2007 |
Sarraf M, Lowes BD, Brieke A, Lindenfeld J, Gray N, Shakar S, Wolfel E, Cleveland J, Bristow MR. Gene Expression Profiles in Idiopathic Dilated Cardiomyopathies, a Validation Study Journal of Cardiac Failure. 13: S109. DOI: 10.1016/J.Cardfail.2007.06.429 |
0.556 |
|
| 2006 |
Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 114: 2766-72. PMID 17159063 DOI: 10.1161/Circulationaha.106.642892 |
0.393 |
|
| 2006 |
Taylor MR, Bristow MR. Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure. Novartis Foundation Symposium. 274: 73-83; discussion 83. PMID 17019807 DOI: 10.1002/0470029331.Ch6 |
0.426 |
|
| 2006 |
Bush EW, Hood DB, Papst PJ, Chapo JA, Minobe W, Bristow MR, Olson EN, McKinsey TA. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. The Journal of Biological Chemistry. 281: 33487-96. PMID 16950785 DOI: 10.1074/Jbc.M605536200 |
0.353 |
|
| 2006 |
Bristow MR. Cardiac resynchronization therapy and adrenergic mechanisms. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2590-1. PMID 16877559 DOI: 10.1152/Ajpheart.00636.2006 |
0.477 |
|
| 2006 |
Liggett SB, Mialet-Perez J, Thaneemit-Chen S, Weber SA, Greene SM, Hodne D, Nelson B, Morrison J, Domanski MJ, Wagoner LE, Abraham WT, Anderson JL, Carlquist JF, Krause-Steinrauf HJ, Lazzeroni LC, ... ... Bristow MR, et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proceedings of the National Academy of Sciences of the United States of America. 103: 11288-93. PMID 16844790 DOI: 10.1073/Pnas.0509937103 |
0.423 |
|
| 2006 |
Lowes BD, Zolty R, Minobe WA, Robertson AD, Leach S, Hunter L, Bristow MR. Serial Gene Expression Profiling in the Intact Human Heart Journal of Heart and Lung Transplantation. 25: 579-588. PMID 16678038 DOI: 10.1016/J.Healun.2006.01.006 |
0.712 |
|
| 2006 |
Sucharov CC, Mariner PD, Nunley KR, Long C, Leinwand L, Bristow MR. A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. American Journal of Physiology. Heart and Circulatory Physiology. 291: H1299-308. PMID 16501029 DOI: 10.1152/Ajpheart.00017.2006 |
0.351 |
|
| 2006 |
Lowes BD, Gottleib S, Thaneemit-Chen S, Robertson AD, O'Connor CM, Port JD, Liggett SB, Bristow MR. Differential Effects of β-1 Polymorphisms on Mortality, Hospitalizations, and Myocardial Infarctions with Bucindolol Therapy Journal of Cardiac Failure. 12: S87. DOI: 10.1016/J.Cardfail.2006.06.295 |
0.543 |
|
| 2006 |
Lowes BD, Zolty R, Abraham WT, Robertson AD, Taylor MR, Liggett SB, Bristow MR. Pharmacogenetic Therapeutic Enhancement of a Prespecified Composite Morbidity-Mortality Measurement in BEST Journal of Cardiac Failure. 12: S87. DOI: 10.1016/J.Cardfail.2006.06.294 |
0.619 |
|
| 2006 |
Sucharov CC, Nelson B, Morrison J, Minobe W, Bristow MR. Gene Expression Changes in Isolated Human Ventricular Preparations Treated with the b-Adrenergic Receptor Agonist Isoproterenol Journal of Cardiac Failure. 12: S44. DOI: 10.1016/J.Cardfail.2006.06.156 |
0.327 |
|
| 2005 |
Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. Journal of Cardiac Failure. 11: 693-9. PMID 16360965 DOI: 10.1016/J.Cardfail.2005.06.435 |
0.469 |
|
| 2005 |
Lowes BD, Shakar SF, Metra M, Feldman AM, Eichhorn E, Freytag JW, Gerber MJ, Liard JF, Hartman C, Gorczynski R, Evans G, Linseman JV, Stewart J, Robertson AD, Roecker EB, ... ... Bristow MR, et al. Rationale and design of the enoximone clinical trials program. Journal of Cardiac Failure. 11: 659-69. PMID 16360960 DOI: 10.1016/J.Cardfail.2005.10.013 |
0.644 |
|
| 2005 |
Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, Ghali J, Ghali J, Barnet JH, Feldman AM, Bristow MR. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology. 46: 2329-34. PMID 16360067 DOI: 10.1016/J.Jacc.2005.09.016 |
0.449 |
|
| 2005 |
Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology. 46: 2311-21. PMID 16360064 DOI: 10.1016/J.Jacc.2005.08.033 |
0.42 |
|
| 2005 |
Rivera DA, Bristow MR. Cardiac resynchronization - A heart failure perspective Annals of Noninvasive Electrocardiology. 10: 16-23. PMID 16274412 DOI: 10.1111/J.1542-474X.2005.00076.X |
0.456 |
|
| 2005 |
Feldman DS, Carnes CA, Abraham WT, Bristow MR. Mechanisms of disease: β-adrenergic receptors - Alterations in signal transduction and pharmacogenomics in heart failure Nature Clinical Practice Cardiovascular Medicine. 2: 475-483. PMID 16265588 DOI: 10.1038/Ncpcardio0309 |
0.354 |
|
| 2005 |
Movsesian MA, Bristow MR. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Current Topics in Developmental Biology. 68: 25-48. PMID 16124995 DOI: 10.1016/S0070-2153(05)68002-7 |
0.374 |
|
| 2005 |
Carniel E, Taylor MR, Sinagra G, Di Lenarda A, Ku L, Fain PR, Boucek MM, Cavanaugh J, Miocic S, Slavov D, Graw SL, Feiger J, Zhu XZ, Dao D, Ferguson DA, ... Bristow MR, et al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation. 112: 54-9. PMID 15998695 DOI: 10.1161/Circulationaha.104.507699 |
0.392 |
|
| 2005 |
Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 111: 2837-49. PMID 15927992 DOI: 10.1161/Circulationaha.104.500546 |
0.472 |
|
| 2005 |
Kinugawa K, Jeong MY, Bristow MR, Long CS. Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Molecular Endocrinology (Baltimore, Md.). 19: 1618-28. PMID 15831522 DOI: 10.1210/Me.2004-0503 |
0.39 |
|
| 2005 |
Domanski M, Fleg J, Bristow M, Knox S. The effect of gender on outcome in digitalis-treated heart failure patients Journal of Cardiac Failure. 11: 83-86. PMID 15732025 DOI: 10.1016/J.Cardfail.2004.07.002 |
0.432 |
|
| 2005 |
Reed MC, Lowes BD, Cantu M, Minobe W, Wolfe E, Lindenfeld J, Zolty R, Shakar S, Bristow M. 250 EFFECT OF THYROID HORMONE ON MYOCARDIAL GENE EXPRESSION, HEMODYNAMICS AND EXERCISE IN HEART FAILURE Journal of Investigative Medicine. 53: S121.4-S121. DOI: 10.2310/6650.2005.00005.249 |
0.698 |
|
| 2005 |
Robinson PF, Tsvetkova TO, Nunley KR, Calalb MB, Sucharov CC, Bristow MR. 103 THE PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA REGULATORY PATHWAY IS ACTIVATED IN PATIENTS WITH SEVERE IDIOPATHIC DILATED CARDIOMYOPATHY Journal of Investigative Medicine. 53: S95.4-S95. DOI: 10.2310/6650.2005.00005.102 |
0.409 |
|
| 2005 |
Eichhorn E, Metra M, Abraham W, Amuchastegui M, Binkley P, Bohm M, Deedwania P, DeMarco T, Elkayam U, Ford I, Ghali J, Guzman L, Klapholz M, Kuschnir E, Liu P, ... ... Bristow M, et al. ESSENTIAL – The Studies of Oral Enoximone Therapy in Advanced Heart Failure Journal of Cardiac Failure. 11: 721. DOI: 10.1016/J.Cardfail.2005.10.010 |
0.644 |
|
| 2005 |
BRISTOW M, NELSON P, MINOBE W, JOHNSON C. Characterization of β1-adrenergic receptor selectivity of nebivolol and various other beta-blockers in human myocardium American Journal of Hypertension. 18: A51-A52. DOI: 10.1016/J.Amjhyper.2005.03.139 |
0.328 |
|
| 2005 |
Bristow MR, Krause-Steinrauf H, Nuzzo R. Heart failure/transplantAbstractsEffect of baseline or changes in adrenergic activity on clinical outcomes in the β-Blocker Evaluation of Survival Trial (BEST) Acc Current Journal Review. 14. DOI: 10.1016/J.Accreview.2004.12.101 |
0.405 |
|
| 2004 |
Taylor MR, Bristow MR. The emerging pharmacogenomics of the beta-adrenergic receptors. Congestive Heart Failure (Greenwich, Conn.). 10: 281-8. PMID 15591842 DOI: 10.1111/J.1527-5299.2004.02019.X |
0.368 |
|
| 2004 |
Pittenger B, Gill EA, Holcslaw TL, Bristow MR. Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 94: 1459-62. PMID 15566928 DOI: 10.1016/J.Amjcard.2004.08.021 |
0.47 |
|
| 2004 |
Sucharov CC, Helmke SM, Langer SJ, Perryman MB, Bristow M, Leinwand L. The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression. Molecular and Cellular Biology. 24: 8705-15. PMID 15367688 DOI: 10.1128/Mcb.24.19.8705-8715.2004 |
0.461 |
|
| 2004 |
Bristow MR, Krause-Steinrauf H, Nuzzo R, Liang CS, Lindenfeld J, Lowes BD, Hattler B, Abraham WT, Olson L, Krueger S, Thaneemit-Chen S, Hare JM, Loeb HS, Domanski MJ, Eichhorn EJ, et al. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation. 110: 1437-42. PMID 15337700 DOI: 10.1161/01.Cir.0000141297.50027.A4 |
0.622 |
|
| 2004 |
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. The New England Journal of Medicine. 350: 2140-50. PMID 15152059 DOI: 10.1056/Nejmoa032423 |
0.456 |
|
| 2004 |
Shakar SF, Lowes BD, Lindenfeld J, Zolty R, Simon M, Robertson AD, Bristow MR, Wolfel EE. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. Journal of Cardiac Failure. 10: 15-20. PMID 14966770 DOI: 10.1016/S1071-9164(03)00593-1 |
0.714 |
|
| 2004 |
Sucharov CC, Nunley KR, Bristow MR. Repression of alpha myosin heavy chain gene expression and promoter activity by the b-agonist isoproterenol – role for Ca2+/calmodulin protein kinase and ERK1/2 pathway Journal of Cardiac Failure. 10: S60. DOI: 10.1016/J.Cardfail.2004.06.155 |
0.45 |
|
| 2004 |
Sucharov CC, Helmke S, Langer S, Perryman B, Bristow MR, Leinwand LA. The ku protein complex interacts with YY1, is up-regulated in human heart failure and represses alpha myosin heavy chain gene expression and promoter activity Journal of Cardiac Failure. 10. DOI: 10.1016/J.Cardfail.2004.06.001 |
0.354 |
|
| 2003 |
Bristow MR, Feldman AM, Adams KF, Goldstein S. Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? Journal of Cardiac Failure. 9: 444-53. PMID 14966783 DOI: 10.1016/J.Cardfail.2003.10.009 |
0.396 |
|
| 2003 |
Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation. 108: 1707-12. PMID 14504186 DOI: 10.1161/01.Cir.0000094734.67990.99 |
0.371 |
|
| 2003 |
Zisman LS, Meixell GE, Bristow MR, Canver CC. Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation. 108: 1679-81. PMID 14504185 DOI: 10.1161/01.Cir.0000094733.61689.D4 |
0.335 |
|
| 2003 |
Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. Journal of the American College of Cardiology. 42: 914-22. PMID 12957443 DOI: 10.1016/S0735-1097(03)00856-8 |
0.614 |
|
| 2003 |
Sucharov CC, Mariner P, Long C, Bristow M, Leinwand L. Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter. The Journal of Biological Chemistry. 278: 31233-9. PMID 12754214 DOI: 10.1074/Jbc.M301917200 |
0.394 |
|
| 2003 |
Abraham WT, Raynolds MV, Badesch DB, Wynne KM, Groves BM, Roden RL, Robertson AD, Lowes BD, Zisman LS, Voelkel NF, Bristow MR, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: Increased frequency and association with preserved haemodynamics Jraas - Journal of the Renin-Angiotensin-Aldosterone System. 4: 27-30. PMID 12692750 DOI: 10.3317/Jraas.2003.003 |
0.594 |
|
| 2003 |
Bristow MR. Microarray measurements of gene expression before and after left ventricular assist device placement. Journal of the American College of Cardiology. 41: 1107-8. PMID 12679208 DOI: 10.1016/S0735-1097(03)00051-2 |
0.305 |
|
| 2003 |
Linseman JV, Bristow MR. Drug therapy and heart failure prevention. Circulation. 107: 1234-6. PMID 12628939 DOI: 10.1161/01.Cir.0000056033.16159.48 |
0.418 |
|
| 2003 |
Bristow M. Antiadrenergic Therapy of Chronic Heart Failure Surprises and New Opportunities Circulation. 107: 1100-1102. PMID 12615784 DOI: 10.1161/01.Cir.0000054530.87613.36 |
0.396 |
|
| 2003 |
Bohlmeyer T, Ferdensi A, Bristow MR, Takahashi S, Zisman LS. Selective activation of N-acyl-D-glucosamine 2-epimerase expression in failing human heart ventricular myocytes. Journal of Cardiac Failure. 9: 59-68. PMID 12612874 DOI: 10.1054/Jcaf.2003.6 |
0.354 |
|
| 2003 |
Bohlmeyer TJ, Helmke S, Ge S, Lynch J, Brodsky G, Sederberg JH, Robertson AD, Minobe W, Bristow MR, Perryman MB. Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 12: 23-31. PMID 12598014 DOI: 10.1016/S1054-8807(02)00127-8 |
0.438 |
|
| 2003 |
Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. Jama. 289: 871-8. PMID 12588271 DOI: 10.1016/S1062-1458(03)00295-2 |
0.354 |
|
| 2003 |
Sucharov CC, Mariner PD, Bristow MR, Long CS, Leinwand LA. YY1 is increased in human heart failure and represses the activity of the human αMyHC promoter Journal of Cardiac Failure. 9: S40. DOI: 10.1016/S1071-9164(03)00497-4 |
0.407 |
|
| 2002 |
Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA, Wolfel EE, Shakar SF, Ferguson D, Volkman K, Linseman JV, Quaife RA, ... ... Bristow MR, et al. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Molecular Medicine (Cambridge, Mass.). 8: 750-60. PMID 12520092 DOI: 10.1007/Bf03402039 |
0.619 |
|
| 2002 |
Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol Journal of the American College of Cardiology. 40: 1248-1258. PMID 12383572 DOI: 10.1016/S0735-1097(02)02134-4 |
0.447 |
|
| 2002 |
Bristow MR, Long CS. Cardiotrophin-1 in heart failure. Circulation. 106: 1430-2. PMID 12234941 DOI: 10.1161/01.Cir.0000034024.61382.42 |
0.342 |
|
| 2002 |
Asano K, Bohlmeyer TJ, Westcott JY, Zisman L, Kinugawa K, Good M, Minobe WA, Roden R, Wolfel EE, Lindenfeld J, David Port J, Perryman MB, Clevel J, Lowes BD, Bristow MR. Altered expression of endothelin receptors in failing human left ventricles Journal of Molecular and Cellular Cardiology. 34: 833-846. PMID 12099722 DOI: 10.1006/Jmcc.2002.2022 |
0.623 |
|
| 2002 |
Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. The New England Journal of Medicine. 346: 1357-65. PMID 11986409 DOI: 10.1056/Nejmoa012630 |
0.636 |
|
| 2002 |
Swedberg K, Bristow MR, Cohn JN, Dargie H, Straub M, Wiltse C, Wright TJ. Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure. Circulation. 105: 1797-803. PMID 11956122 DOI: 10.1161/01.Cir.0000014212.04920.62 |
0.411 |
|
| 2002 |
Leier CV, Silver MA, Rich MW, Eichhorn EJ, Fowler MB, Giles TD, Johnstone DE, Le Jemtel TH, Lachmann JS, Levine TB, Armstrong PW, Dec WG, Jessup M, Howlett J, Hershberger RE, ... ... Bristow MR, et al. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. Congestive Heart Failure (Greenwich, Conn.). 8: 98-124. PMID 11927786 |
0.327 |
|
| 2002 |
CVL, Jessup M, Giles TD, Johnstone DE, Ventura HO, Dec WG, Levine TB, Eichhorn EJ, Feldman AM, Bristow MR, Pina IL, Binkley PF. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 3--Diagnostic studies: laboratory testing. Congestive Heart Failure. 8: 49-53. PMID 11821628 DOI: 10.1111/J.1527-5299.2002.01168.X |
0.417 |
|
| 2002 |
Wolfel EE, Tsvetkova TO, Lowes BD, Lindenfeld J, Shakar SF, Abraham WT, Robertson AD, Gilbert EM, Bristow MR. Improved ventilatory response at peak exercise despite no change in peak oxygen consumption with chronic beta-blockade in heart failure patients Journal of the American College of Cardiology. 39: 183. DOI: 10.1016/S0735-1097(02)80810-5 |
0.415 |
|
| 2002 |
Zolty R, Passarino G, Taylor M, Moss A, Mestroni L, Bristow M. Molecular epidemiology of cardiac actin gene mutations in dilated cardiomyopathy Journal of the American College of Cardiology. 39: 178. DOI: 10.1016/S0735-1097(02)80789-6 |
0.507 |
|
| 2002 |
Tsvetkova TO, Lowes BD, Robertson AD, Shakar SF, Lindenfeld J, Bristow MR, Wolfel EE. Ventilatory response to exercise in heart failure patients treated with beta-blockers is a better predictor of survival than peak oxygen consumption Journal of the American College of Cardiology. 39: 147. DOI: 10.1016/S0735-1097(02)80650-7 |
0.632 |
|
| 2001 |
Leier CV, Young JB, Levine TB, Pina I, Armstrong PW, Fowler MB, Warner-Stevenson L, Cohn JN, O'Connell JB, Bristow MR, Nicklas JM, Johnstone DE, Howlett J, Ventura HO, Giles TD, et al. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congestive Heart Failure (Greenwich, Conn.). 7: 297-308. PMID 11828174 DOI: 10.1111/J.1527-5299.2001.01167.X |
0.314 |
|
| 2001 |
Eichhorn EJ, Bristow MR. The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Current Controlled Trials in Cardiovascular Medicine. 2: 20-23. PMID 11806769 DOI: 10.1186/Cvm-2-1-020 |
0.45 |
|
| 2001 |
Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. International Journal of Cardiology. 81: 141-9. PMID 11744130 DOI: 10.1016/S0167-5273(01)00520-4 |
0.627 |
|
| 2001 |
Lindenfeld J, Robertson AD, Lowes BD, Bristow MR. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers Journal of the American College of Cardiology. 38: 1950-1956. PMID 11738299 DOI: 10.1016/S0735-1097(01)01641-2 |
0.684 |
|
| 2001 |
Bristow MR, Shakar SF, Linseman JV, Lowes BD. Inotropes and beta-blockers: is there a need for new guidelines? Journal of Cardiac Failure. 7: 8-12. PMID 11605160 DOI: 10.1054/Jcaf.2001.26655 |
0.632 |
|
| 2001 |
Kinugawa K, Long CS, Bristow MR. Expression of TR isoforms in failing human heart. The Journal of Clinical Endocrinology and Metabolism. 86: 5089-90. PMID 11600594 DOI: 10.1210/Jcem.86.10.7963-3 |
0.418 |
|
| 2001 |
Kinugawa K, Yonekura K, Ribeiro RCJ, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy Circulation Research. 89: 591-598. PMID 11577024 DOI: 10.1161/Hh1901.096706 |
0.358 |
|
| 2001 |
Loh E, Elkayam U, Cody R, Bristow M, Jaski B, Colucci WS. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure Journal of Cardiac Failure. 7: 114-121. PMID 11420762 DOI: 10.1054/Jcaf.2001.24136 |
0.401 |
|
| 2001 |
Asano K, Zisman LS, Yoshikawa T, Headley V, Bristow MR, Port JD. Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes. Journal of Cardiovascular Pharmacology. 37: 678-91. PMID 11392464 DOI: 10.1097/00005344-200106000-00005 |
0.371 |
|
| 2001 |
Eichhorn EJ, Domanski MJ, Krause-Steinrauf H, Bristow MR, Lavori PW. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. The New England Journal of Medicine. 344: 1659-67. PMID 11386264 DOI: 10.1056/Nejm200105313442202 |
0.486 |
|
| 2001 |
Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. Journal of the American College of Cardiology. 37: 1692-9. PMID 11345386 DOI: 10.1016/S0735-1097(01)01190-1 |
0.411 |
|
| 2001 |
Port JD, Bristow MR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. Journal of Molecular and Cellular Cardiology. 33: 887-905. PMID 11343413 DOI: 10.1006/Jmcc.2001.1358 |
0.442 |
|
| 2001 |
Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure New England Journal of Medicine. 344: 1358-1365. PMID 11333992 DOI: 10.1056/Nejm200105033441803 |
0.444 |
|
| 2001 |
Freeman K, Lerman I, Kranias EG, Bohlmeyer T, Bristow MR, Lefkowitz RJ, Iaccarino G, Koch WJ, Leinwand LA. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. The Journal of Clinical Investigation. 107: 967-74. PMID 11306600 DOI: 10.1172/Jci12083 |
0.481 |
|
| 2001 |
Shakar SF, Bristow MR. Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents. Current Cardiology Reports. 3: 224-31. PMID 11305977 DOI: 10.1007/S11886-001-0027-8 |
0.497 |
|
| 2001 |
Schleman KA, Lindenfeld JA, Lowes BD, Bristow MR, Ferguson D, Wolfel EE, Abraham WT, Zisman LS. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. Journal of Cardiac Failure. 7: 4-12. PMID 11264544 DOI: 10.1054/Jcaf.2001.22491 |
0.663 |
|
| 2001 |
Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RCJ, Tawadrous MF, Lowes BA, Long CS, Bristow MR. Signaling pathways responsible for fetal gene induction in the failing human heart: Evidence for altered thyroid hormone receptor gene expression Circulation. 103: 1089-1094. PMID 11222471 DOI: 10.1161/01.Cir.103.8.1089 |
0.34 |
|
| 2001 |
Bristow MR. Of phospholamban, mice, and humans with heart failure. Circulation. 103: 787-788. PMID 11171783 DOI: 10.1161/01.Cir.103.6.787 |
0.477 |
|
| 2000 |
Bristow M. Etomoxir: a new approach to treatment of chronic heart failure. The Lancet. 356: 1621-1622. PMID 11089814 DOI: 10.1016/S0140-6736(00)03149-4 |
0.41 |
|
| 2000 |
Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 102: IV14-23. PMID 11080127 DOI: 10.1161/01.Cir.102.Suppl_4.Iv-14 |
0.491 |
|
| 2000 |
Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial Journal of Cardiac Failure. 6: 276-285. PMID 10997756 DOI: 10.1054/Jcaf.2000.9501 |
0.431 |
|
| 2000 |
Lowes BD, Higginbotham M, Petrovich L, DeWood MA, Greenberg MA, Rahko PS, Dec GW, LeJemtel TH, Roden RL, Schleman MM, Robertson AD, Gorczynski RJ, Bristow MR. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. Journal of the American College of Cardiology. 36: 501-8. PMID 10933364 DOI: 10.1016/S0735-1097(00)00759-2 |
0.579 |
|
| 2000 |
Bristow MR. What type of beta-blocker should be used to treat chronic heart failure? Circulation. 102: 484-6. PMID 10920055 DOI: 10.1161/01.Cir.102.5.484 |
0.414 |
|
| 2000 |
Noori A, Lindenfeld J, Wolfel E, Ferguson D, Bristow MR, Lowes BD. Beta-blockade in adriamycin-induced cardiomyopathy. Journal of Cardiac Failure. 6: 115-9. PMID 10908085 |
0.583 |
|
| 2000 |
Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. Journal of Molecular and Cellular Cardiology. 32: 817-30. PMID 10775486 DOI: 10.1006/Jmcc.2000.1123 |
0.384 |
|
| 2000 |
Lowes BD, Simon MA, Tsvetkova TO, Bristow MR. Inotropes in the beta-blocker era. Clinical Cardiology. 23: III11-6. PMID 10754776 DOI: 10.1002/Clc.4960231504 |
0.614 |
|
| 2000 |
Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart Circulation Research. 86: 386-390. PMID 10700442 DOI: 10.1161/01.Res.86.4.386 |
0.398 |
|
| 2000 |
Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation. 101: 558-69. PMID 10662755 DOI: 10.1161/01.Cir.101.5.558 |
0.46 |
|
| 2000 |
Bristow MR. Mechanisms of development of heart failure in the hypertensive patient. Cardiology. 3-6; discussion 7-9,. PMID 10652966 DOI: 10.1159/000047287 |
0.484 |
|
| 2000 |
Noori A, Lindenfeld J, Wolfel E, Ferguson D, Bristow MR, Lowes BD. β-Blockade in adriamycin-induced cardiomyopathy Journal of Cardiac Failure. 6: 115-119. DOI: 10.1016/S1071-9164(00)90013-7 |
0.599 |
|
| 1999 |
Lindenfeld J, Lowes BD, Bristow MR. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. The Annals of Pharmacotherapy. 33: 1266-9. PMID 10630826 DOI: 10.1345/Aph.19111 |
0.545 |
|
| 1999 |
Gwathmey JK, Kim CS, Hajjar RJ, Khan F, DiSalvo TG, Matsumori A, Bristow MR. Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. The American Journal of Physiology. 276: H1678-90. PMID 10330254 DOI: 10.1152/Ajpheart.1999.276.5.H1678 |
0.428 |
|
| 1999 |
Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure American Journal of Cardiology. 83: 1201-1205. PMID 10215284 DOI: 10.1016/S0002-9149(99)00059-4 |
0.656 |
|
| 1999 |
Quaife RA, Lynch D, Badesch DB, Voelkel NF, Lowes BD, Robertson AD, Bristow MR. Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy Journal of Cardiac Failure. 5: 46-54. PMID 10194660 DOI: 10.1016/S1071-9164(99)90024-6 |
0.613 |
|
| 1999 |
Gerdes AM, Onodera T, Tamura T, Said S, Bohlmeyer TJ, Abraham WT, Bristow MR. New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material. Journal of Cardiac Failure. 4: 343-8. PMID 9924856 DOI: 10.1016/S1071-9164(98)90240-8 |
0.434 |
|
| 1999 |
Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, Mintze K, Pickard T, Roden R, Bristow MR, Sabbah HN, Mizrahi JL, Gromo G, King GL, Vlahos CJ. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation. 99: 384-91. PMID 9918525 DOI: 10.1161/01.Cir.99.3.384 |
0.45 |
|
| 1999 |
Asano K, Zisman LS, Bristow MR. Heart Failure Reviews. 3: 199-208. DOI: 10.1023/A:1009709500372 |
0.37 |
|
| 1999 |
Lowes BD, Wolfel E, Gilbert EM, Abraham WT, Ferguson D, Robertson AD, Minobe WA, Bristow MR. β-blocker related improvement in exercise capacity is associated with increased expression of SR Ca+2-ATPase Journal of Cardiac Failure. 5: 23. DOI: 10.1016/S1071-9164(99)91428-8 |
0.53 |
|
| 1999 |
Zolty R, Brodsky GL, Benjamin Perryman M, Bristow MR, Mestroni L. Epidemiology of cardiac actin gene mutations in dilated cardiomyopathy Journal of Cardiac Failure. 5: 23. DOI: 10.1016/S1071-9164(99)91426-4 |
0.56 |
|
| 1998 |
Bristow MR. Carvedilol tratment of chronic heart failure: a new era. Heart. 79: 31. PMID 18610474 DOI: 10.1136/Hrt.79.2008.31S |
0.433 |
|
| 1998 |
Bristow MR, Roden RL, Lowes BD, Gilbert EM, Eichhorn EJ. The role of third-generation beta-blocking agents in chronic heart failure. Clinical Cardiology. 21: I3-13. PMID 9853189 |
0.568 |
|
| 1998 |
Zisman LS, Asano K, Dutcher DL, Ferdensi A, Robertson AD, Jenkin M, Bush EW, Bohlmeyer T, Perryman MB, Bristow MR. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart. Circulation. 98: 1735-41. PMID 9788827 DOI: 10.1161/01.Cir.98.17.1735 |
0.378 |
|
| 1998 |
Bristow MR, Zisman LS, Lowes BD, Abraham WT, Badesch DB, Groves BM, Voelkel NF, Lynch DMB, Quaife RA. The pressure-overloaded right ventricle in pulmonary hypertension Chest. 114: 101S-106S. PMID 9676654 DOI: 10.1378/Chest.114.1_Supplement.101S |
0.518 |
|
| 1998 |
Quaife RA, Christian PE, Gilbert EM, Datz FL, Volkman K, Bristow MR. Effects of carvedilol on right ventricular function in chronic heart failure. The American Journal of Cardiology. 81: 247-50. PMID 9591916 DOI: 10.1016/S0002-9149(97)00874-6 |
0.458 |
|
| 1998 |
Shakar SF, Abraham WT, Gilbert EM, Robertson AD, Lowes BD, Zisman LS, Ferguson DA, Bristow MR. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure Journal of the American College of Cardiology. 31: 1336-1343. PMID 9581729 DOI: 10.1016/S0735-1097(98)00077-1 |
0.66 |
|
| 1998 |
Bristow MR. Tumor necrosis factor-alpha and cardiomyopathy. Circulation. 97: 1340-1. PMID 9577943 DOI: 10.1161/01.Cir.97.14.1340 |
0.358 |
|
| 1998 |
Abraham WT, Lowes BD, Ferguson DA, Odom J, Kim JK, Robertson AD, Bristow MR, Schrier RW. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. Journal of Cardiac Failure. 4: 37-44. PMID 9573502 DOI: 10.1016/S1071-9164(98)90506-1 |
0.625 |
|
| 1998 |
Bristow M, Port JD. Beta-adrenergic blockade in chronic heart failure. Scandinavian Cardiovascular Journal. Supplement. 47: 45-55. PMID 9540133 DOI: 10.1080/140174398428045 |
0.478 |
|
| 1998 |
Bristow MR. Mechanism of action of beta-blocking agents in heart failure. The American Journal of Cardiology. 80: 26L-40L. PMID 9412540 DOI: 10.1016/S0002-9149(97)00846-1 |
0.428 |
|
| 1998 |
Lowes BD, Wolfel EE, Rizeq MN, Bristow MR, Zisman LS, Lindenfeld J. FK506 IS A SAFE AND EFFECTIVE TREATMENT FOR MODERATE REJECTION IN HEART TRANSPLANT RECIPIENTS. Transplantation. 65: 231. DOI: 10.1097/00007890-199805131-00610 |
0.585 |
|
| 1998 |
Tsvetkova TO, Farber DJ, Abraham WT, Kelley P, Eichhorn E, Gilbert EM, Robertson AD, Lindenfeld J, Wolfel EE, Zisman L, Bristow MR, Lowes BD. Comparative hemodynamic effects of milrinone and dobutamine in heart failure patients treated chronically with carvedilol Journal of Cardiac Failure. 4: 36. DOI: 10.1016/S1071-9164(98)90134-8 |
0.657 |
|
| 1998 |
Roden RL, Asano K, Wichman S, Hoover E, Bristow MR, Abraham WT. Inotropic effect of human b-type natriuretic peptide in the failing human heart Journal of Cardiac Failure. 4: 19. DOI: 10.1016/S1071-9164(98)90071-9 |
0.328 |
|
| 1998 |
Abraham WT, Tsvetkova T, Lowes BD, Ferguson DA, Gilbert E, Bristow MR. Carvedilol improves renal hemodynamics in patients with chronic heart failure Journal of Cardiac Failure. 4: 3. DOI: 10.1016/S1071-9164(98)90008-2 |
0.584 |
|
| 1998 |
Bowling N, Estridge T, Fouts R, Song G, Roden R, Bristow M, Walsh R, Sabbah H, Sandusky G, Mizrahi J, Gromo G, Vlahos C. Increased protein kinase C expression in failing human heart Journal of the American College of Cardiology. 31: 203-204. DOI: 10.1016/S0735-1097(98)81523-4 |
0.354 |
|
| 1997 |
Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure Journal of Clinical Investigation. 100: 2362-2370. PMID 9410916 DOI: 10.1172/Jci119776 |
0.477 |
|
| 1997 |
Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AO, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR. Changes in gene expression in the intact human heart: Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium Journal of Clinical Investigation. 100: 2315-2324. PMID 9410910 DOI: 10.1172/Jci119770 |
0.658 |
|
| 1997 |
Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation. 96: 2755-7. PMID 9386129 DOI: 10.1161/01.Cir.96.9.2755 |
0.446 |
|
| 1997 |
Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA. Safety and efficacy of carvedilol in severe heart failure Journal of Cardiac Failure. 3: 173-179. PMID 9330125 DOI: 10.1016/S1071-9164(97)90013-0 |
0.493 |
|
| 1997 |
Bristow MR, Abraham WT, Yoshikawa T, White M, Hattler BG, Crisman TS, Lowes BD, Robertson AD, Larrabee P, Gilbert EM. Second- and third-generation beta-blocking drugs in chronic heart failure. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 11: 291-6. PMID 9211023 DOI: 10.1023/A:1007748131847 |
0.666 |
|
| 1997 |
Eichhorn EJ, Bristow MR. Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure. The American Journal of Cardiology. 79: 794-8. PMID 9070564 DOI: 10.1016/S0002-9149(96)00873-9 |
0.347 |
|
| 1997 |
Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation. 95: 1193-200. PMID 9054849 DOI: 10.1161/01.Cir.95.5.1193 |
0.326 |
|
| 1997 |
Cohn JN, Bristow MR, Chien KR, Colucci WS, Frazier OH, Leinwand LA, Lorell BH, Moss AJ, Sonnenblick EH, Walsh RA, Mockrin SC, Reinlib L. Report of the National Heart, Lung, and Blood Institute special emphasis panel on heart failure research Circulation. 95: 766-770. PMID 9054723 DOI: 10.1161/01.Cir.95.4.766 |
0.407 |
|
| 1997 |
Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 94: 2817-25. PMID 8941107 DOI: 10.1161/01.Cir.94.11.2817 |
0.496 |
|
| 1997 |
Cleland JG, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Beta-blocking agents in heart failure. Should they be used and how? European Heart Journal. 17: 1629-39. PMID 8922910 DOI: 10.1093/Oxfordjournals.Eurheartj.A014745 |
0.459 |
|
| 1997 |
Bristow MR, Abraham WT. Anti-adrenergic effects of angiotensin converting enzyme inhibitors. European Heart Journal. 37-41. PMID 8869134 DOI: 10.1093/Eurheartj/16.Suppl_K.37 |
0.441 |
|
| 1996 |
Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation. 94: 2807-2816. PMID 8941106 DOI: 10.1161/01.Cir.94.11.2807 |
0.38 |
|
| 1996 |
Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure Circulation. 94: 2800-2806. PMID 8941105 DOI: 10.1161/01.Cir.94.11.2800 |
0.483 |
|
| 1996 |
Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 94: 2285-96. PMID 8901684 DOI: 10.1161/01.Cir.94.9.2285 |
0.496 |
|
| 1996 |
Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. The American Journal of Cardiology. 78: 779-84. PMID 8857482 DOI: 10.1016/S0002-9149(96)00420-1 |
0.481 |
|
| 1996 |
Yoshikawa T, Port JD, Asano K, Chidiak P, Bouvier M, Dutcher D, Roden RL, Minobe W, Tremmel KD, Bristow MR. Cardiac adrenergic receptor effects of carvedilol. European Heart Journal. 17: 8-16. PMID 8733065 DOI: 10.1093/Eurheartj/17.Suppl_B.8 |
0.434 |
|
| 1996 |
Focaccio A, Peeters G, Movsesian M, Roden R, Eki Y, Krall J, Bristow MR. Mechanism of action of OPC-8490 in human ventricular myocardium. Circulation. 93: 817-25. PMID 8641012 DOI: 10.1161/01.Cir.93.4.817 |
0.327 |
|
| 1996 |
Pende A, Tremmel KD, DeMaria CT, Blaxall BC, Minobe WA, Sherman JA, Bisognano JD, Bristow MR, Brewer G, Port JD. Regulation of the mRNA-binding protein AUF1 by activation of the β- adrenergic receptor signal transduction pathway Journal of Biological Chemistry. 271: 8493-8501. PMID 8626551 DOI: 10.1074/Jbc.271.14.8493 |
0.311 |
|
| 1996 |
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure New England Journal of Medicine. 334: 1349-1355. PMID 8614419 DOI: 10.1056/Nejm199605233342101 |
0.464 |
|
| 1996 |
Bristow MR, Gilbert EM. Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure. European Heart Journal. 20-31. PMID 8521881 DOI: 10.1093/Eurheartj/16.Suppl_F.20 |
0.464 |
|
| 1996 |
Gilbert EM, Hershberger RE, Wiechmann RJ, Movsesian MA, Bristow MR. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. Chest. 108: 1524-32. PMID 7497755 DOI: 10.1378/Chest.108.6.1524 |
0.423 |
|
| 1996 |
Roden RL, Minobe WA, Dutcher DL, Tremmel KD, Port J, Bristow MR. Differential regulation of β1 and β2 andrenergic receptors and mRNA by non-selective β agonist exposure in preparations of isolation human heart Journal of the American College of Cardiology. 27: 288. DOI: 10.1016/S0735-1097(96)82045-6 |
0.305 |
|
| 1996 |
Raynolds MV, Roden RL, Blain-Nelson P, Bristow MR, Perryman M. Association of genetic variants in the angiotensin II type 1 receptor and angiotensinogen with end-stage heart muscle disease Journal of the American College of Cardiology. 27: 27. DOI: 10.1016/S0735-1097(96)80294-4 |
0.316 |
|
| 1995 |
Jaggers J, Fullerton DA, Campbell DN, Andrea B, Jones SD, Brown JM, Wolfel EE, Lindenfeld J, Grover FL, Bristow MR. Cardiac allograft failure: successful use of biventricular assist device. The Annals of Thoracic Surgery. 60: 1409-11. PMID 8526640 DOI: 10.1016/0003-4975(95)00498-A |
0.365 |
|
| 1995 |
Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 92: 3593-612. PMID 8521589 DOI: 10.1161/01.Cir.92.12.3593 |
0.469 |
|
| 1995 |
Hunt SA, Bristow MR, Kubo SH, O'Connell JB, Young JB. Task Force 8: Training in heart failure and transplantation Journal of the American College of Cardiology. 25: 29-31. PMID 7798519 DOI: 10.1016/0735-1097(95)96222-K |
0.35 |
|
| 1995 |
Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study Journal of the American College of Cardiology. 25: 1225-1231. PMID 7722114 DOI: 10.1016/0735-1097(95)00012-S |
0.497 |
|
| 1995 |
Abraham WT, Raynolds MV, Gottschall B, Badesch DB, Wynne KM, Groves BM, Lowes BD, Bristow MR, Perryman MB, Voelkel NF. Importance of angiotensin-converting enzyme in pulmonary hypertension Cardiology (Switzerland). 86: 9-15. PMID 7614507 DOI: 10.1159/000176939 |
0.588 |
|
| 1995 |
White M, Yanowitz F, Gilbert EM, Larrabee P, O'Connell JB, Anderson JL, Renlund D, Mealey P, Abraham WT, Bristow MR. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 76: 1271-6. PMID 7503009 DOI: 10.1016/S0002-9149(99)80355-5 |
0.449 |
|
| 1995 |
Asano K, Minobe W, Mitchusson KD, Dutcher D, Roden RL, David Port J, Bristow MR. 776-1 Selective Down-regulation of Angiotensin II AT 1 Receptors in Failing Human Heart: Relationship to β 1 -Receptor Down-regulation Journal of the American College of Cardiology. 25: 291A-292A. DOI: 10.1016/0735-1097(95)92667-T |
0.358 |
|
| 1995 |
Minobe W, Lowes BD, Abraham WT, Feldman AM, Bristow MR. 766-2 In Vivo Measurement of Myocardial Gene Expression in the Human Heart Journal of the American College of Cardiology. 25: 277A. DOI: 10.1016/0735-1097(95)92608-8 |
0.582 |
|
| 1995 |
Abraham WT, Lowes BD, Ferguson DA, Wolfel EE, Lindenfeld J, Schrier RW, Bristow MR. 757-6 Systemic Hemodynamic and Renal Excretory Effects of a Continuous 4-Hour Infusion of Human Brain Natriuretic Peptide in Patients with Heart Failure Journal of the American College of Cardiology. 25: 236A. DOI: 10.1016/0735-1097(95)92437-A |
0.644 |
|
| 1995 |
Zisman LS, Abraham WT, Meixell GE, Vamvakias BN, Lowes BD, Roden RL, Quaife RA, Groves BM, Perryman MB, Bristow MR. 757-2 Angiotensin II Formation in the Intact Human Heart: Predominance of the Angiotensin Converting Enzyme Pathway Journal of the American College of Cardiology. 25: 234A-235A. DOI: 10.1016/0735-1097(95)92433-6 |
0.566 |
|
| 1995 |
Meixell GE, Wangsgaard WP, Blumenthal DK, Bristow MR. 718-5 Differential Regulation of Phosphorylase Kinase in Failing Human Left Ventricular Myocardium Journal of the American College of Cardiology. 25: 91A. DOI: 10.1016/0735-1097(95)91832-I |
0.418 |
|
| 1995 |
Abraham WT, Raynolds MV, Badesch DB, Lowes BD, Groves BM, Wynne KM, Voelkel NF, Perryman MB, Bristow MR. 901-94 The Angiotensin Converting Enzyme DD Genotype is Associated with Preserved Right Ventricular Function in Patients with Severe Primary Pulmonary Hypertension Journal of the American College of Cardiology. 25: 27A-28A. DOI: 10.1016/0735-1097(95)91571-E |
0.556 |
|
| 1994 |
Abraham WT, Lowes BD, White M, Ferguson DA, Scheffel CA, Wolfel EE, Lindenfeld J, Bristow MR. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure. Journal of Cardiac Failure. 1: 57-62. PMID 9420633 DOI: 10.1016/1071-9164(94)90008-6 |
0.66 |
|
| 1994 |
Bristow MR, Lowes BD. Low-dose inotropic therapy for ambulatory heart failure. Coronary Artery Disease. 5: 112-8. PMID 7910094 DOI: 10.1097/00019501-199402000-00004 |
0.643 |
|
| 1994 |
Bristow MR, O'Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, Orie J, Smucker ML, Marshall G, Kelly P. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. Circulation. 89: 1632-42. PMID 7908610 DOI: 10.1161/01.Cir.89.4.1632 |
0.475 |
|
| 1994 |
Bristow MR. Ischemie cardiomyopathy and heart failure Edited by Michael R. Bristow Coronary Artery Disease. 5: 97-100. DOI: 10.1097/00019501-199402000-00001 |
0.412 |
|
| 1993 |
Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. The New England Journal of Medicine. 329: 149-55. PMID 8515787 DOI: 10.1056/Nejm199307153290301 |
0.448 |
|
| 1993 |
Bristow MR. Changes in myocardial and vascular receptors in heart failure. Journal of the American College of Cardiology. 22: 61A-71A. PMID 8397233 DOI: 10.1016/0735-1097(93)90465-D |
0.465 |
|
| 1993 |
Gilbert EM, Sandoval A, Larrabee P, Renlund DG, O'Connell JB, Bristow MR. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart. Circulation. 88: 472-80. PMID 8393389 DOI: 10.1161/01.Cir.88.2.472 |
0.469 |
|
| 1993 |
Olsen SL, Renlund DG, O’ Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR. Prevention of pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole Transplantation. 56: 359-362. PMID 8356591 DOI: 10.1097/00007890-199308000-00021 |
0.305 |
|
| 1993 |
Ensley RD, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O’connell JB, Dunn D, Osburn L, Jones KW, Kauffman RS, Gay WA, Renlund DG. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients Transplantation. 56: 75-82. PMID 8333071 DOI: 10.1097/00007890-199307000-00013 |
0.333 |
|
| 1993 |
Bristow MR, Minobe WA, Reynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM. Reduced β1, receptor messenger RNA abundance in the failing human heart Journal of Clinical Investigation. 92: 2737-2745. PMID 8254027 DOI: 10.1172/Jci116891 |
0.354 |
|
| 1993 |
Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (London, England). 342: 1073-5. PMID 8105309 DOI: 10.1016/0140-6736(93)92061-W |
0.364 |
|
| 1993 |
Gilbert EM, Olsen SL, Renlund DG, Bristow MR. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy The American Journal of Cardiology. 71. PMID 8096672 DOI: 10.1016/0002-9149(93)90083-O |
0.407 |
|
| 1993 |
Bristow MR. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. The American Journal of Cardiology. 71: 12C-22C. PMID 8096671 DOI: 10.1016/0002-9149(93)90082-N |
0.495 |
|
| 1993 |
Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 342: 1441-6. PMID 7902479 DOI: 10.1016/0140-6736(93)92930-R |
0.423 |
|
| 1992 |
Feldman AM, Ray PE, Bristow MR. Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. Journal of Molecular and Cellular Cardiology. 23: 1355-8. PMID 1811054 DOI: 10.1016/0022-2828(91)90182-L |
0.336 |
|
| 1992 |
Ratkovec RM, Hammond EH, O'Connell JB, Bristow MR, DeWitt CW, Richenbacher WE, Millar RC, Renlund DG. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch--preliminary results with plasmapheresis. Transplantation. 54: 651-5. PMID 1412756 DOI: 10.1097/00007890-199210000-00017 |
0.301 |
|
| 1992 |
Bristow MR, Larrabee P, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD, Müller-Beckmann B. Receptor pharmacology of carvedilol in the human heart. Journal of Cardiovascular Pharmacology. S68-80. PMID 1378154 DOI: 10.1097/00005344-199219001-00014 |
0.357 |
|
| 1992 |
Bristow MR, Larrabee P, Müller-Beckmann B, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. The Clinical Investigator. S105-13. PMID 1350478 DOI: 10.1007/Bf00207620 |
0.377 |
|
| 1992 |
Bristow MR, Feldman AM. Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease. Basic Research in Cardiology. 15-35. PMID 1323259 DOI: 10.1007/978-3-642-72474-9_2 |
0.43 |
|
| 1992 |
Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. The New England Journal of Medicine. 326: 1182-6. PMID 1313549 DOI: 10.1056/Nejm199204303261803 |
0.336 |
|
| 1992 |
Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. The Journal of Clinical Investigation. 89: 803-15. PMID 1311717 DOI: 10.1172/Jci115659 |
0.453 |
|
| 1992 |
Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation. Circulation. 85: 46-53. PMID 1309447 DOI: 10.1161/01.Cir.85.1.46 |
0.442 |
|
| 1991 |
Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 83: 1866-72. PMID 2040039 DOI: 10.1161/01.Cir.83.6.1866 |
0.407 |
|
| 1991 |
Feldman AM, Jackson DG, Bristow MR, Cates AE, Van Dop C. Immunodetectable levels of the inhibitory guanine nucleotide-binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. Journal of Molecular and Cellular Cardiology. 23: 439-52. PMID 1942080 DOI: 10.1016/0022-2828(91)90168-L |
0.353 |
|
| 1991 |
Richenbacher WE, Karwande SV, Shaddy RE, Renlund DG, Bristow MR, O'Connell JB, Gay WA. Cardiac transplantation in a patient with a single ventricle and transposition of the great vessels. The Annals of Thoracic Surgery. 52: 871-3. PMID 1929647 DOI: 10.1016/0003-4975(91)91233-L |
0.377 |
|
| 1991 |
Hershberger RE, Feldman AM, Bristow MR. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium. Circulation. 83: 1343-51. PMID 1901530 DOI: 10.1161/01.Cir.83.4.1343 |
0.345 |
|
| 1991 |
Hershberger RE, Feldman AM, Anderson FL, Kimball JA, Wynn JR, Bristow MR. Mr 40,000 and Mr 39,000 pertussis toxin substrates are increased in surgically denervated dog ventricular myocardium. Journal of Cardiovascular Pharmacology. 17: 568-75. PMID 1711622 DOI: 10.1097/00005344-199104000-00007 |
0.335 |
|
| 1991 |
Gilbert EM, O'Connell JB, Bristow MR. Therapy of idiopathic dilated cardiomyopathy with chronic β-adrenergic blockade Heart and Vessels. 6: 29-39. PMID 1687924 DOI: 10.1007/Bf01752533 |
0.405 |
|
| 1991 |
Anderson JL, Gilbert EM, O'Connell JB, Renlund D, Yanowitz F, Murray M, Roskelley M, Mealey P, Volkman K, Deitchman D, Bristow M. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy Journal of the American College of Cardiology. 17: 1373-1381. PMID 1673132 DOI: 10.1016/S0735-1097(10)80150-0 |
0.364 |
|
| 1991 |
Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 84: 1024-39. PMID 1653120 DOI: 10.1161/01.Cir.84.3.1024 |
0.418 |
|
| 1991 |
Movsesian MA, Smith CJ, Krall J, Bristow MR, Manganiello VC. Sarcoplasmic reticulum-associated cyclic adenosine 5′-monophosphate phosphodiesterase activity in normal and failing human hearts Journal of Clinical Investigation. 88: 15-19. PMID 1647414 DOI: 10.1172/Jci115272 |
0.39 |
|
| 1991 |
Lee HR, Hershberger RE, Port JD, Rasmussen R, Renlund DG, O’Connell JB, Gilbert EM, Mealey PC, Volkman K, Menlove R, Bristow MR. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. The Journal of Thoracic and Cardiovascular Surgery. 102: 246-258. DOI: 10.1016/S0022-5223(19)36557-2 |
0.417 |
|
| 1991 |
Focaccio A, Larrabee P, Wollmering MM, Bristow MR. Xamoterol has agonist activity in end-stage failing human heart Journal of the American College of Cardiology. 17: A250. DOI: 10.1016/0735-1097(91)91967-J |
0.382 |
|
| 1991 |
Focaccio A, Minobe W, Movsesian MA, Krall J, Peeters G, Eki Y, Bristow MR. Evidence for phosphodiesterase inhibitory activity of OPC 8490 in the failing human heart Journal of the American College of Cardiology. 17: A250. DOI: 10.1016/0735-1097(91)91966-I |
0.405 |
|
| 1991 |
Minobe W, Larrabee P, Bristow MR. Mechanism of action of carvedilol in human ventricular myocardium Journal of the American College of Cardiology. 17: A250. DOI: 10.1016/0735-1097(91)91965-H |
0.323 |
|
| 1991 |
Pickrell J, Hammond E, Larrabee P, Bristow M. Comparison of sympathetic innervation of failing and nonfailing human hearts by quantitative evaluation of catecholamine fluorescence Journal of the American College of Cardiology. 17: A220. DOI: 10.1016/0735-1097(91)91846-7 |
0.375 |
|
| 1991 |
Lenarda AD, Gilbert EM, Olsen SL, Mealey PC, Bristow MR. Acute hemodynamic effects of carvedilol versus metoprolol in idiopathic dilated cardiomyopathy Journal of the American College of Cardiology. 17: A142. DOI: 10.1016/0735-1097(91)91533-K |
0.33 |
|
| 1991 |
Bristow MR, Skerl L, Larrabee P, Minobe W, Rasmussen R, Ginsburg R. An abnormality in the catalytic subunit of adenylate cyclase characterizes pressure-overloaded, failing human ventricular myocardium Journal of the American College of Cardiology. 17: A100. DOI: 10.1016/0735-1097(91)91368-O |
0.314 |
|
| 1990 |
Bristow MR. The surgically denervated, transplanted human heart. Circulation. 82: 658-60. PMID 2372914 DOI: 10.1161/01.Cir.82.2.658 |
0.367 |
|
| 1990 |
Rasmussen RP, Minobe W, Bristow MR. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Biochemical Pharmacology. 39: 691-6. PMID 2154992 DOI: 10.1016/0006-2952(90)90147-D |
0.362 |
|
| 1990 |
Feldman AM, Bristow MR. The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy. Cardiology. 1-32. PMID 1970755 DOI: 10.1159/000174645 |
0.433 |
|
| 1990 |
Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR. Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo The American Journal of Medicine. 88: 223-229. PMID 1968710 DOI: 10.1016/0002-9343(90)90146-5 |
0.41 |
|
| 1990 |
Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, Hershberger RE, Murray J, Bristow MR. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation. 81: 929-38. PMID 1968367 DOI: 10.1161/01.Cir.81.3.929 |
0.449 |
|
| 1990 |
Hershberger RE, Wynn JR, Sundberg L, Bristow MR. Mechanism of action of bucindolol in human ventricular myocardium. Journal of Cardiovascular Pharmacology. 15: 959-67. PMID 1694919 DOI: 10.1097/00005344-199006000-00014 |
0.363 |
|
| 1990 |
Renlund DG, O'Connell JB, Bristow MR. Strategies of immunosuppression in cardiac transplantation Seminars in Thoracic and Cardiovascular Surgery. 2: 181-188. DOI: 10.5555/Uri:Pii:104306799090028L |
0.307 |
|
| 1990 |
Hershberger RE, Kimball JA, Minobe W, Rasmussen R, Bristow MR. Muscarinic receptor pathways in nonfailing and failing human heart Journal of the American College of Cardiology. 15: A171. DOI: 10.1016/0735-1097(90)92402-N |
0.396 |
|
| 1990 |
Port J, Skerl L, O'Connell JB, Renlund DG, Larrabee P, Bristow MR. Increased expression of β 2 -adrenergic receptors in surgically denervated, previously transplanted human ventricular myocardium Journal of the American College of Cardiology. 15: A84. DOI: 10.1016/0735-1097(90)92054-6 |
0.337 |
|
| 1990 |
Wiechmann RJ, Eastburn T, Murray J, Port J, O'Connell JB, Renlund DG, Hershberger RE, Bristow MR. Cardiac donor heart dysfunction: Evidence for catecholamine-mediated myocardial injury Journal of the American College of Cardiology. 15: A84. DOI: 10.1016/0735-1097(90)92052-4 |
0.406 |
|
| 1990 |
Woodley SL, O'Connell JB, Renlund DG, Herrick CM, Gay WA, Jones KW, Moore CK, Bristow MR. Safety and efficacy of intraoperative vs postoperative administration of okt3 in orthotopic cardiac transplantation Journal of the American College of Cardiology. 15: A69. DOI: 10.1016/0735-1097(90)91992-4 |
0.301 |
|
| 1990 |
Bristow MR, Renlund DG, Gilbert EM, O'Connell JB. Enoximone in severe heart failure: Clinical results and effects on β-adrenergic receptors International Journal of Cardiology. 28. DOI: 10.1016/0167-5273(90)90146-V |
0.391 |
|
| 1989 |
Shaddy RE, Mak C, Bristow MR. Comparative in vitro myocardial inotropic effects and in vivo hemodynamic effects of forskolin and isoproterenol in young lambs. Pediatric Research. 25: 580-4. PMID 2740148 DOI: 10.1203/00006450-198906000-00005 |
0.378 |
|
| 1989 |
O'Connell JB, Renlund DG, Bristow MR. Cardiac transplantation: Emerging role of the internist/cardiologist Journal of Internal Medicine. 225: 147-156. PMID 2649631 DOI: 10.1111/J.1365-2796.1989.Tb00056.X |
0.32 |
|
| 1989 |
Bristow MR, Port JD, Hershberger RE, Gilbert EM, Feldman AM. The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure. European Heart Journal. 45-54. PMID 2572420 DOI: 10.1093/Eurheartj/10.Suppl_B.45 |
0.442 |
|
| 1989 |
Movsesian MA, Bristow MR, Krall J. Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy Circulation Research. 65: 1141-1144. PMID 2551528 DOI: 10.1161/01.Res.65.4.1141 |
0.362 |
|
| 1989 |
Hershberger RE, Anderson FL, Bristow MR. Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density. Circulation Research. 65: 283-94. PMID 2546693 DOI: 10.1161/01.Res.65.2.283 |
0.347 |
|
| 1989 |
Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 79: 483-90. PMID 2537158 DOI: 10.1161/01.Cir.79.3.483 |
0.435 |
|
| 1989 |
Gilbert EM, Eiswirth CC, Mealey PC, Larrabee P, Herrick CM, Bristow MR. Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Circulation. 79: 344-9. PMID 2536597 DOI: 10.1161/01.Cir.79.2.344 |
0.414 |
|
| 1989 |
Feldman AM, Cates AE, Bristow MR, Van Dop C. Altered expression of alpha-subunits of G proteins in failing human hearts. Journal of Molecular and Cellular Cardiology. 21: 359-65. PMID 2501499 DOI: 10.1016/0022-2828(89)90646-9 |
0.33 |
|
| 1988 |
Gilbert EM, Krueger SK, Murray JL, Renlund DG, O'Connell JB, Gay WA, Bristow MR. Echocardiographic evaluation of potential cardiac transplant donors Journal of Thoracic and Cardiovascular Surgery. 95: 1003-1007. PMID 3287011 DOI: 10.1016/S0022-5223(19)35666-1 |
0.398 |
|
| 1988 |
Bristow MR, Gilbert EM, O'Connell JB, Renlund DG, Watson FS, Hammond E, Lee RG, Menlove R. OKT3 monoclonal antibody in heart transplantation. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 11: 135-40. PMID 3277404 DOI: 10.1016/S0272-6386(88)80198-7 |
0.304 |
|
| 1988 |
Bristow MR, Sandoval AB, Gilbert EM, Deisher T, Minobe W, Rasmussen R. Myocardial alpha- and beta-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? European Heart Journal. 35-40. PMID 2844538 DOI: 10.1093/Eurheartj/9.Suppl_H.35 |
0.463 |
|
| 1988 |
Anderson FL, Kralios AC, Hershberger R, Bristow MR. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs. The American Journal of Physiology. 255: H601-7. PMID 2843056 DOI: 10.1152/Ajpheart.1988.255.3.H601 |
0.361 |
|
| 1988 |
Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. The Journal of Clinical Investigation. 82: 189-97. PMID 2839545 DOI: 10.1172/Jci113569 |
0.377 |
|
| 1987 |
Gilbert EM, Bristow MR, Mason JW. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study. The American Journal of Cardiology. 60: 57C-62C. PMID 2956870 DOI: 10.1016/0002-9149(87)90527-3 |
0.389 |
|
| 1987 |
Bristow MR, Ginsburg R, Gilbert EM, Hershberger RE. Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart. Basic Research in Cardiology. 369-76. PMID 2821984 DOI: 10.1007/978-3-662-11289-2_36 |
0.425 |
|
| 1986 |
Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 74: 1290-302. PMID 3022962 DOI: 10.1161/01.Cir.74.6.1290 |
0.449 |
|
| 1986 |
Bristow MR, Ginsburg R. Beta 2 receptors on myocardial cells in human ventricular myocardium. The American Journal of Cardiology. 57: 3F-6F. PMID 3010694 DOI: 10.1016/0002-9149(86)90880-5 |
0.347 |
|
| 1986 |
Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circulation Research. 59: 297-309. PMID 2876788 DOI: 10.1161/01.Res.59.3.297 |
0.378 |
|
| 1985 |
Schroeder JS, Beier-Scott L, Ginsburg R, Bristow MR, McAuley BJ. Efficacy of diltiazem for medically refractory stable angina: long-term follow-up. Clinical Cardiology. 8: 480-5. PMID 2864152 DOI: 10.1002/Clc.4960080905 |
0.32 |
|
| 1985 |
Bristow MR, Kantrowitz NE, Ginsburg R, Fowler MB. Beta-adrenergic function in heart muscle disease and heart failure. Journal of Molecular and Cellular Cardiology. 41-52. PMID 2863387 DOI: 10.1016/0022-2828(85)90007-0 |
0.464 |
|
| 1985 |
Fowler MB, Bristow MR. Rationale for beta-adrenergic blocking drugs in cardiomyopathy. The American Journal of Cardiology. 55: 120D-124D. PMID 2859789 DOI: 10.1016/0002-9149(85)91066-5 |
0.448 |
|
| 1984 |
Bristow MR. The adrenergic nervous system in heart failure. The New England Journal of Medicine. 311: 850-1. PMID 6472388 DOI: 10.1056/Nejm198409273111310 |
0.437 |
|
| 1984 |
Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W. Pharmacology and inotropic potential of forskolin in the human heart. The Journal of Clinical Investigation. 74: 212-23. PMID 6330174 DOI: 10.1172/Jci111404 |
0.428 |
|
| 1984 |
Bristow MR. Myocardial beta-adrenergic receptor downregulation in heart failure. International Journal of Cardiology. 5: 648-52. PMID 6325351 DOI: 10.1016/0167-5273(84)90179-7 |
0.473 |
|
| 1983 |
Bristow MR. Toxic cardiomyopathy due to doxorubicin. Hospital Practice (Office Ed.). 17: 101-8, 110-1. PMID 6815051 DOI: 10.1080/21548331.1982.11702439 |
0.383 |
|
| 1983 |
Torti FM, Bristow MR, Howes AE, Aston D, Stockdale FE, Carter SK, Kohler M, Brown BW, Billingham ME. Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. Annals of Internal Medicine. 99: 745-9. PMID 6651020 DOI: 10.7326/0003-4819-99-6-745 |
0.333 |
|
| 1983 |
McKillop JH, Bristow MR, Goris ML, Billingham ME, Bockemuehl K. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. American Heart Journal. 106: 1048-56. PMID 6637763 DOI: 10.1016/0002-8703(83)90651-8 |
0.328 |
|
| 1983 |
Ginsburg R, Bristow MR, Billingham ME, Stinson EB, Schroeder JS, Harrison DC. Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. American Heart Journal. 106: 535-40. PMID 6308994 DOI: 10.1016/0002-8703(83)90698-1 |
0.38 |
|
| 1983 |
Bristow MR, Kantrowitz NE, Harrison WD, Minobe WA, Sageman WS, Billingham ME. Mediation of subacute anthracycline cardiotoxicity in rabbits by cardiac histamine release. Journal of Cardiovascular Pharmacology. 5: 913-9. PMID 6196562 DOI: 10.1097/00005344-198311000-00002 |
0.362 |
|
| 1983 |
Ginsburg R, Esserman LJ, Bristow MR. Myocardial performance and extracellular ionized calcium in a severely failing human heart. Annals of Internal Medicine. 98: 603-6. PMID 6133487 DOI: 10.7326/0003-4819-98-5-603 |
0.416 |
|
| 1983 |
Lurie KG, Bristow MR, Reitz BA. Increased β-adrenergic receptor density in an experimental model of cardiac transplantation The Journal of Thoracic and Cardiovascular Surgery. 86: 195-201. DOI: 10.1016/S0022-5223(19)39176-7 |
0.339 |
|
| 1982 |
Bristow MR, Ginsburg R, Harrison DC. Histamine and the human heart: The other receptor system The American Journal of Cardiology. 49: 249-251. PMID 7032271 DOI: 10.1016/0002-9149(82)90298-3 |
0.335 |
|
| 1982 |
Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. The New England Journal of Medicine. 307: 205-11. PMID 6283349 DOI: 10.1056/NEJM198207223070401 |
0.313 |
|
| 1982 |
Clusin WT, Bristow MR, Karagueuzian HS, Katzung BG, Schroeder JS. Do calcium-dependent ionic currents mediate ischemic ventricular fibrillation? The American Journal of Cardiology. 49: 606-612. PMID 6277181 DOI: 10.1016/S0002-9149(82)80019-2 |
0.304 |
|
| 1982 |
Lurie KG, Billingham ME, Masek MA, Ginsburg R, Bristow MR, Harrison DC, Reitz BA. Ultrastructural and functional studies on prolonged myocardial preservation in an experimental heart transplant model The Journal of Thoracic and Cardiovascular Surgery. 84: 122-129. DOI: 10.1016/S0022-5223(19)39526-1 |
0.365 |
|
| 1982 |
Clusin WT, Baim DS, Bristow MR, Schroeder JS, Harrison DC. Anti-fibrillatory action of diltiazem during global left ventricular ischemia The American Journal of Cardiology. 49: 913. DOI: 10.1016/0002-9149(82)92061-6 |
0.303 |
|
| 1981 |
Bristow MR, Mason JW, Billingham ME, Daniels JR. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. American Heart Journal. 102: 709-18. PMID 7282516 DOI: 10.1016/0002-8703(81)90096-X |
0.308 |
|
| 1980 |
Bristow MR, Sageman WS, Scott RH, Billingham ME, Bowden RE, Kernoff RS, Snidow GH, Daniels JR. Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release. Journal of Cardiovascular Pharmacology. 2: 487-515. PMID 6157945 DOI: 10.1097/00005344-198009000-00002 |
0.324 |
|
| 1980 |
Ginsburg R, Bristow MR, Stinson EB, Harrison DC. Histamine receptors in the human heart. Life Sciences. 26: 2245-9. PMID 6105606 DOI: 10.1016/0024-3205(80)90209-X |
0.323 |
|
| 1978 |
Bristow MR, Thompson PD, Martin RP, Mason JW, Billingham ME, Harrison DC. Early anthracycline cardiotoxicity. The American Journal of Medicine. 65: 823-32. PMID 707541 DOI: 10.1016/0002-9343(78)90802-1 |
0.404 |
|
| 1978 |
Bristow MR, Mason JW, Billingham ME, Daniels JR. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Annals of Internal Medicine. 88: 168-75. PMID 626445 DOI: 10.7326/0003-4819-88-2-168 |
0.413 |
|
| 1977 |
Bristow MR, Schwartz HD, Binetti G, Harrison DC, Daniels JR. Ionized calcium and the heart. Elucidation of in vivo concentration-response relationships in the open-chest dog. Circulation Research. 41: 565-74. PMID 902363 DOI: 10.1161/01.Res.41.4.565 |
0.334 |
|
| 1970 |
Bristow M, Green RD. A quantitative study of beta-adrenergic receptors in rabbit atria European Journal of Pharmacology. 12: 120-123. PMID 4394343 DOI: 10.1016/0014-2999(70)90037-3 |
0.328 |
|
| Show low-probability matches. |